Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness

Beth S. Woods, Eleftherios Sideris, Matthew R. Sydes, Melissa R. Gannon, Mahesh K.B. Parmar, Mymoona Alzouebi, Gerhardt Attard, Alison J. Birtle, Susannah Brock, Richard Cathomas, Prabir R. Chakraborti, Audrey Cook, William R. Cross, David P. Dearnaley, Joanna Gale, Stephanie Gibbs, John D. Graham, Robert Hughes, Rob J. Jones, Robert LaingMalcolm D. Mason, David Matheson, Duncan B. McLaren, Robin Millman, Joe M. O'Sullivan, Omi Parikh, Christopher C. Parker, Clive Peedell, Andrew Protheroe, Alastair W.S. Ritchie, Angus Robinson, J. Martin Russell, Matthew S. Simms, Narayanan N. Srihari, Rajaguru Srinivasan, John N. Staffurth, Santhanam Sundar, George N. Thalmann, Shaun Tolan, Anna T.H. Tran, David Tsang, John Wagstaff, Nicholas D. James, Mark J. SculpherShow 24 moreShow less